Stock Scorer

Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Harvard Apparatus Regenerative Technology, Inc. reported revenue of 414K USD for the quarter ending 30 June 2026, up 30.6% from 317K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 414K +30.6%
Gross Profit Q4 '17 · ending 31 December 2017 0 —
Operating Income Q2 '26 · ending 30 June 2026 -1.7M —
Net Income Q2 '26 · ending 30 June 2026 -1.7M —
Cost of Revenue Q2 '26 · ending 30 June 2026 391K +29.5%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -569K —
Free Cash Flow Q4 '23 · ending 31 December 2023 -1.2M —
Shares Outstanding Q2 '26 · ending 30 June 2026 17.6M +10.4%
EPS Q2 '26 · ending 30 June 2026 -0.39 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 704K-6.9M-6.9M—
20242024-12-31 430K-7.7M-7.7M-4.9M
20232023-12-31 103K-9M-8.9M-7M
20212021-12-31 0-8.6M-8M-2.6M
20202020-12-31 0-5.3M-4.9M-4M
20192019-12-31 0-8.9M-8.3M-6.2M
20182018-12-31 0-7.8M-7.5M-7.8M
20172017-12-31 0-11.5M-11.9M-11.2M
20162016-12-31 82K-12.1M-11.6M-9.4M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30414K
Q1 '262026-03-31226K
Q4 '252025-12-31219K
Q3 '252025-09-30123K
Q2 '252025-06-30317K
Q1 '252025-03-3145K
Q4 '242024-12-31258K
Q3 '242024-09-3059K
Q2 '242024-06-3056K
Q1 '242024-03-3157K
Q4 '232023-12-3163K
Q3 '232023-09-3040K
Q2 '222022-06-300
Q1 '222022-03-310
Q4 '212021-12-310
Q3 '212021-09-300
Q2 '212021-06-300
Q1 '212021-03-310
Q4 '202020-12-310
Q3 '202020-09-300

Gross Profit Quarterly

PeriodEndingGross Profit
Q4 '172017-12-310
Q3 '172017-09-300
Q2 '172017-06-300
Q1 '172017-03-310
Q4 '162016-12-31-31K
Q3 '162016-09-3013K
Q2 '162016-06-30-16K
Q1 '162016-03-310
Q4 '152015-12-31-76K
Q3 '152015-09-3019K
Q2 '152015-06-3036K
Q1 '152015-03-310
Q4 '142014-12-3122K
Q3 '142014-09-301K
Q2 '142014-06-3011K
Q1 '142014-03-3111K
Q4 '132013-12-3111K
Q3 '132013-09-300
Q2 '132013-06-300
Q1 '132013-03-310

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-1.7M
Q1 '262026-03-31-1.6M
Q4 '252025-12-31-1.7M
Q3 '252025-09-30-1.7M
Q2 '252025-06-30-1.8M
Q1 '252025-03-31-1.7M
Q4 '242024-12-31-1.4M
Q3 '242024-09-30-1.9M
Q2 '242024-06-30-2.5M
Q1 '242024-03-31-2M
Q4 '232023-12-31-1.8M
Q3 '232023-09-30-1.6M
Q2 '232023-06-30-2.7M
Q1 '232023-03-31-2.9M
Q4 '222022-12-31-1.5M
Q3 '222022-09-30-1.1M
Q2 '222022-06-30-1.4M
Q1 '222022-03-31-2.2M
Q4 '212021-12-31-5.9M
Q3 '212021-09-30-822K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-1.7M
Q1 '262026-03-31-1.6M
Q4 '252025-12-31-1.7M
Q3 '252025-09-30-1.7M
Q2 '252025-06-30-1.8M
Q1 '252025-03-31-1.7M
Q4 '242024-12-31-1.3M
Q3 '242024-09-30-1.9M
Q2 '242024-06-30-2.5M
Q1 '242024-03-31-2M
Q4 '232023-12-31-1.8M
Q3 '232023-09-30-1.6M
Q2 '232023-06-30-2.6M
Q1 '232023-03-31-2.9M
Q4 '222022-12-31-1.5M
Q3 '222022-09-30-1.1M
Q2 '222022-06-30-1.3M
Q1 '222022-03-31-2.2M
Q4 '212021-12-31-5.9M
Q3 '212021-09-30-849K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30391K
Q1 '262026-03-31206K
Q4 '252025-12-31199K
Q3 '252025-09-30112K
Q2 '252025-06-30302K
Q1 '252025-03-3133K
Q4 '242024-12-31175K
Q3 '242024-09-3070K
Q2 '242024-06-3013K
Q1 '242024-03-3112K
Q4 '172017-12-310
Q3 '172017-09-300
Q2 '172017-06-300
Q1 '172017-03-310
Q4 '162016-12-3159K
Q3 '162016-09-3013K
Q2 '162016-06-3044K
Q1 '162016-03-310
Q4 '152015-12-3184K
Q3 '152015-09-3018K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-569K
Q1 '262026-03-31-937K
Q4 '252025-12-31-664K
Q3 '252025-09-30-1.5M
Q2 '252025-06-30-941K
Q1 '252025-03-31-758K
Q4 '242024-12-31-1.1M
Q3 '242024-09-30-1.5M
Q2 '242024-06-30-1.3M
Q1 '242024-03-31-960K
Q4 '232023-12-31-1.2M
Q3 '232023-09-30-3.2M
Q2 '232023-06-30-1.5M
Q1 '232023-03-31-1M
Q4 '222022-12-31-1.7M
Q3 '222022-09-30-1.7M
Q2 '222022-06-30-1.1M
Q1 '222022-03-31-519K
Q4 '212021-12-31-1M
Q3 '212021-09-30-454K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '232023-12-31-1.2M
Q3 '232023-09-30-3.2M
Q2 '232023-06-30-1.5M
Q1 '232023-03-31-1M
Q3 '222022-09-30-1.7M
Q4 '212021-12-31-1M
Q4 '202020-12-31-1M
Q3 '202020-09-30-862K
Q2 '202020-06-30-1.1M
Q1 '202020-03-31-1.1M
Q4 '192019-12-31-1.5M
Q3 '192019-09-30-1.4M
Q2 '192019-06-30-2.1M
Q1 '192019-03-31-1.2M
Q4 '182018-12-31-2.2M
Q3 '182018-09-30-2.3M
Q2 '182018-06-30-1.3M
Q1 '182018-03-31-2.1M
Q4 '172017-12-31-1.7M
Q3 '172017-09-30-3.2M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3017.6M
Q1 '262026-03-3117.6M
Q3 '252025-09-3017M
Q2 '252025-06-3015.9M
Q1 '252025-03-3115.9M
Q3 '242024-09-3015M
Q2 '242024-06-3014.3M
Q1 '242024-03-3113.9M
Q3 '232023-09-3013.9M
Q2 '232023-06-3013.8M
Q1 '232023-03-3112.2M
Q3 '222022-09-3011.6M
Q2 '222022-06-3011.2M
Q1 '222022-03-3110.8M
Q3 '212021-09-3010M
Q2 '212021-06-309.7M
Q1 '212021-03-319.4M
Q3 '202020-09-308.9B

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.39
Q1 '262026-03-31-0.40
Q4 '252025-12-31-0.41
Q3 '252025-09-30-0.39
Q2 '252025-06-30-0.41
Q1 '252025-03-31-0.48
Q4 '242024-12-31-0.53
Q3 '242024-09-30-0.58
Q2 '242024-06-30-0.58
Q1 '242024-03-31-0.59
Q4 '232023-12-31-0.68
Q3 '232023-09-30-0.68
Q2 '232023-06-30-0.66
Q1 '232023-03-31-0.59
Q4 '222022-12-31-0.55
Q3 '222022-09-30-0.99
Q2 '222022-06-30-0.97
Q1 '222022-03-31-0.89
Q4 '212021-12-31-0.78
Q3 '212021-09-30-0.31